Mast cell chymase and carboxypeptidase A play key roles in the non-ACE-dependent generation and degradation of Angiotensin II.
Authors
No takes yet. Share an insight, caveat, or question.
Does not alter ACE inhibitor use; leaves open mast cell chymase/CPA targeting in Ang II pathways pending in vivo and human studies.
Lundequist et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: